Proactive Investors - Run By Investors For Investors

Daily CryptoCann Report: Buffett and Gates have harsh words for Bitcoin; Marijuana Index on the decline

It's not the first time the Oracle of Omaha's comments have spooked cryptocurrency investors
Crypto coins
EOS was the only cryptocurrency not in the red

Four of the top five cryptocurrencies were in the red Monday after comments from multibillionaires Warren Buffett and Bill Gates.

Prior to Berkshire Hathaway’s annual meeting, Buffett described Bitcoin as “probably rat poison squared” and said that it will never produce any value for investors.

Bill Gates told CNBC that he would short Bitcoin if he could. He called cryptocurrencies “crazy, speculative things” and said that cryptocurrency investing is “a pure ‘greater fool theory’ type of investment.”

READ: Daily CryptoCann Report: Bitcoin heist suspect escapes; new East Coast dispensaries to open

EOS was the only cryptocurrency to rise, recovering from last week’s downward streak.

Bitcoin Cash (BCH-USD) was the top decliner, down more than 6% to US$1,641.39.

Ethereum (ETH-USD) was the second-largest decliner, down nearly 6% to US$744.88.

Ripple (XRP-USD) fell more than 4% to US$0.83 while Bitcoin (BTC-USD) was down nearly 3% to US$9,383.47.

The North American Marijuana Index, comprised of the leading cannabis stocks in the US and Canada, fell more than 1%.

Medical cannabis company Sunniva Inc (OTCQX:SNNVF) saw a share boost after announcing the site of its Canadian facility. The Vancouver-based company has selected a 126-acre zone in Okanagan Falls, British Columbia, as part of a $7 million agreement. Shares were up less than 1% to US$6.84.

Research and development company Scythian Biosciences Corp (OTCQB:SCCYF) entered into an agreement with cannabis company Isodiol International Inc (OTCMKTS:ISOLF)  to import Isodiol products throughout the Caribbean as well as Central and South America. Scythian Biosciences develops treatments and preventions for concussions and traumatic brain injuries through cannabinoid-based drugs. The Toronto-based company also invested $2 million into Isodiol. Shares of Scythian were down nearly 5% to US$3.07 while shares of Isodiol were also down around 5% to US$0.56.

View full ISOL profile View Profile

Isodiol International Timeline

Related Articles

September 05 2018
During the completion of its phase 1 exploration program at Bujagali and associated infill sampling, M2 Cobalt discovered six additional large-scale anomalies with highly anomalous rock and soil samples
computing symbols in cyberspace
January 16 2019
Its team of computer scientists designs algorithms that will be used by high-frequency traders, scientists doing genetic research and pharmaceutical companies

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use